← All stories
Markets
Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress
2 outlets - including Investing and Bloomberg - are covering this story. Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.
Covered by 2 outlets
All coverage · 2 articles
Investing.com News
·2h ago
Qiagen names Jonathan Pratt as CEO amid takeover talks
Bloomberg Markets
·3h ago
Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress
Qiagen NV has appointed Jonathan Pratt as its new chief executive officer, as talks with private equity firms about a possible sale of the European molecular testing company progress.